CHCHD10 Knockout 3T3-L1 Cell Line

The choice depends on whether you are studying CHCHD10's role as a mitochondrial intermembrane space CHCHD-domain protein or modeling CHCHD10-associated ALS/FTD and other neuromuscular disorders. The Knockout line is the standard tool for asking whether CHCHD10 is required for these processes — CHCHD10 is a small intermembrane space protein with a twin CX9C motif characteristic of MIA40-imported mitochondrial proteins; CHCHD10 partners with CHCHD2 and has been characterized in mitochondrial cristae morphology, complex I assembly, and apoptosis regulation. Overexpression is useful for studying CHCHD10 in heterologous expression contexts. For neuromuscular disease research, the EDITGENE Chchd10 Knockout in 3T3-L1 enables study of Chchd10 biology in adipocyte metabolic context. CHCHD10 missense mutations (S59L, R15L, P34S, G66V, others) cause autosomal dominant amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), myopathy, Charcot-Marie-Tooth disease, and other neuromuscular disorders — CHCHD10 has emerged as a major ALS/FTD/myopathy gene. Rescue with wild-type or patient-derived CHCHD10 mutations enables disease genotype-function studies. The knockout is valuable for studying mitochondrial intermembrane space biology and CHCHD10-related neuromuscular disease mechanisms.

Primary applications: • Mitochondrial IMS biology: in 3T3-L1 context, mitochondrial intermembrane space morphology and complex I assembly analysis. • ALS/FTD modeling: rescue with patient-derived CHCHD10 mutations (S59L, R15L, P34S, G66V) for genotype-function studies of CHCHD10-ALS/FTD/myopathy. • Adipocyte differentiation: in 3T3-L1 differentiation context, characterization of CHCHD10's role in adipocyte mitochondrial biogenesis. • Apoptosis regulation: cytochrome c release and apoptosis sensitivity given CHCHD10's IMS localization. EDITGENE recommends this 3T3-L1-based model for researchers investigating CHCHD10 biology, ALS/FTD/myopathy disease mechanisms, and mitochondrial IMS biology.

Yes. Chchd10 rescue experiments require attention to mitochondrial intermembrane space targeting: • Construct design: use a codon-modified Chchd10 sequence with a small C-terminal tag (FLAG, HA). CHCHD10 has N-terminal MIA40-targeting signal and twin CX9C CHCH motif requiring proper disulfide bond formation in the IMS — preserve all cysteines. • IMS localization validation: confirm intermembrane space localization (proteinase K accessibility with intact outer membrane). • ALS/FTD mutation rescue: S59L, R15L, P34S, G66V mutations enable disease modeling — these mutations cause autosomal dominant gain-of-toxicity phenotypes. • Functional readout: rescue should restore mitochondrial cristae morphology; ALS mutants should recapitulate disease phenotypes. 3T3-L1-specific considerations: • 3T3-L1 is a murine preadipocyte cell line (Swiss albino mouse origin) — the principal continuous cell model for adipocyte differentiation, insulin signaling, and lipid metabolism research; can be induced to differentiate into mature adipocytes with insulin/IBMX/dexamethasone cocktail. • Lentiviral transduction is supported with moderate efficiency. • Characterize preadipocyte state and differentiation efficiency before phenotypic assays.